Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSEN

scientific article published on 06 May 2009

Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSEN is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.01761-08
P932PMC publication ID2708481
P698PubMed publication ID19420172

P2093author name stringLesley E Scott
Linda Erasmus
Wendy Stevens
Willem D F Venter
Jackie Moloi
Lara D Noble
P2860cites workMeasuring agreement in method comparison studiesQ28145208
Molecular beacons: probes that fluoresce upon hybridizationQ28274024
HIV-1 viral load assays for resource-limited settingsQ33259966
Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South AfricaQ33824797
Diagnosis of HIV infection and laboratory monitoring of its therapyQ34277009
Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasmaQ34419917
How many people are currently infected with HIV in South Africa?Q34663512
Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeaeQ35690738
Evaluation of the performance of the automated NucliSENS easyMAG and EasyQ systems versus the Roche AmpliPrep-AMPLICOR combination for high-throughput monitoring of human immunodeficiency virus loadQ35784400
Molecular assays for monitoring HIV infection and antiretroviral therapyQ36816024
Thermodynamic basis of the enhanced specificity of structured DNA probesQ37200381
Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assayQ38885775
Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domainQ38978220
Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South AfricaQ39753822
Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and BotswanaQ40798969
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA loadQ41072830
Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR Version 1.5 conventional PCR assayQ42030505
Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCRQ42160975
Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QTQ42211051
Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparationQ42408684
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assaysQ42637939
Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.Q43039006
Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.Q43040408
Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South AfricaQ43682159
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypesQ45052445
Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan systemQ45406680
Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) anQ45423609
Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patientsQ46713961
Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT).Q46777621
Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridizationQ46960543
Multiple method comparison: statistical model using percentage similarityQ47802478
Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine.Q51081557
Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.Q51092043
Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays.Q51154109
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.Q51467024
Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets.Q53573165
Quantitative measurement of HIV RNA: techniques & clinical applications.Q54014878
Appropriate laboratory monitoring of HIV.Q54058667
Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil.Q54615727
Monitoring HIV viral loads in the United States: recent trends and methodologiesQ74230694
Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the amplicor HIV-1 monitor assayQ78008158
Performance of the Abbott RealTime HIV-1 assay for quantification of HIV-1 clades prevalent in ChinaQ80804384
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectSouth AfricaQ258
HIVQ15787
P304page(s)2209-2217
P577publication date2009-05-06
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleEvaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSEN
P478volume47

Reverse relations

cites work (P2860)
Q35189996Abbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction
Q94570568Accurate HIV viral load measurement in primary health care settings using the cobas® plasma separation card
Q35273824An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study
Q33647158Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men.
Q34547246Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece
Q84380599Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia
Q37050729Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda
Q34487510Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections
Q34301929Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation
Q38088726Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.
Q92570580Early infant diagnosis HIV-1 PCR cycle-threshold predicts infant viral load at birth
Q38417936Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification
Q36173963Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load
Q42113208HIV-1 Load Comparison Using Four Commercial Real-Time Assays
Q64108555Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome
Q30248647Laboratory Innovation Towards Quality Program Sustainability
Q36228238Options to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert® HIV-1 Viral Load Assay
Q36779718Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.
Q47909581Prospective evaluation of a new automated nucleic acid extraction system using routine clinical respiratory specimens
Q37217809Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis
Q35099443Systematic review of the performance of HIV viral load technologies on plasma samples
Q35802992The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes
Q35551811Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR
Q36414140Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing.